Erschienen in:
04.02.2017 | LETTER TO THE EDITOR
Comment on “Potential Effects of Calcium Binding Protein S100A12 on Severity Evaluation and Curative Effect of Severe Acute Pancreatitis”
verfasst von:
Vahid Bagheri, Carolyn L. Geczy
Erschienen in:
Inflammation
|
Ausgabe 5/2017
Einloggen, um Zugang zu erhalten
Excerpt
Feng and colleagues recently investigated the role of the calcium binding protein, S100A12, in severe acute pancreatitis. They reported that this is induced by caerulein and lipopolysaccharide in mice and anti-recombinant S100A12 antibodies decreased severity [
1]. They suggest that “S100A12 is a mediator, not a marker, of acute pancreatitis” and that inhibiting it may represent a novel therapeutic approach. Based on reagents used in this study (antibodies raised against human recombinant S100A12 as immunogen) and strong evidence for the absence of S100A12 in the mouse genome [
2,
3], we found that conclusions drawn from this publication are misleading. …